SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MedImmune
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sim1 who wrote (238)12/16/2002 1:54:54 PM
From: tom pope  Read Replies (1) of 416
 
Briefing at 13.20:
MedImmune: Solly finds FDA analysis of FluMist to be equivocal to negative (25.58 -1.06) -- Update --
Salomon Smith Barney believes the FDA has presented an analysis of MEDI's FluMist that is generally equivocal to negative towards approval, and finds the FDA's commentary to be "surprisingly more negative" than expected; with a positive outcome, firm believes the stock should experi
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News